Healthcare Industry Synthetic Biology Market Research Report 2024 | Page 2

Your Catalyst To a Lucrative Business
As per applications, the segments are healthcare, agriculture, bio-fuels, chemicals, and others. “Others”
includes energy & environment, biosecurity, and R&D. Healthcare applications held the largest share in the
global industry in 2013. Factors that fuel this segment are high production of nutraceuticals for supplements,
newer therapies, vitamins, regenerative medicine, and for reprogramming stem cells. Technology-wise, the
synthetic biology market is categorized into biological components, genome engineering, integrated systems,
DNA sequencing, and bioinformatics. Genome engineering generated highest revenues for the global industry
in 2013. Considerable progress in this field has reaped substantial market returns.
Geographical segments of the overall synthetic biology market are Asia Pacific, North America, Europe, and
RoW (Rest of the World). Due to a strong technological base, inclination towards in-depth R&D activities, and
favorable governmental initiatives, North America dominates the worldwide market. Widespread awareness
among patients is another vital driver in the region. However, due to surging healthcare spending and
consciousness about hospital acquired infections, China and India can exhibit positive growth trends. This may
stand to benefit the entire Asia Pacific region over the forecast period (2016 to 2024). Key companies operating
in the worldwide market are Bioneer Corporation, Cobalt Technologies, Evolva SA, Gene Script Corporation, and
Exxon Mobil Corporation.
Synthetic biology is increasingly being used by scientists to develop genetic circuits that can be planted in cells
for the production of useful molecules & drugs. However, the genetic components may interfere with one
another because of complexities in the genetic circuits. Researchers at MIT have developed ways in which these
circuits can be separated in each synthetic cell. Interactions between these cells can also be controlled; which
in turn enables the circuits to be combined at certain times. The synthetic cells in question are not living cells
but contain enough cellular machinery to produce proteins and read DNA.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-
category/biotechnology-industry
Follow Us: